Results 101 to 110 of about 8,176 (156)

Tongxie Yaofang ameliorates IBS-D by targeting the gut microbiota-derived tryptophan metabolites and AhR signaling axis. [PDF]

Front Microbiol
Xie X, Yan W, Gan C, Xiong W, Huang Y, Lin L, Lei X, Ke W, Chai Y, Tang H, Zhu H.   +10 more
europepmc   +1 more source

The Impact of Rifaximin on Hepatic Encephalopathy during Lenvatinib Therapy in Patients with Hepatocellular Carcinoma and Splenorenal Shunt. [PDF]

Intern Med
Shimose S, Iwamoto H, Niizeki T, Shirono T, Moriyama E, Kawaguchi T.   +5 more
europepmc   +1 more source

C-Reactive Protein Levels Predict Improvement in the Liver Functional Reserve by Long-Term Rifaximin Treatment. [PDF]

Diseases
Kitsugi K, Kawata K, Murohisa G, Yoshizawa Y, Kimata M, Kobayashi Y, Unno S, Noritake H, Chida T, Hosoda Y.   +9 more
europepmc   +1 more source

Sociodemographic disparities in documented nonadherence to medication for hepatic encephalopathy: a National Inpatient Sample analysis. [PDF]

Ann Gastroenterol
Behrend C, Ali Y, Akambase JA, Goble SR, Leventhal TM.   +4 more
europepmc   +1 more source

Rifaximin-induced changes in the gut microbiome associated to improvement of neurotransmission alterations and learning in rats with chronic liver disease. [PDF]

Sci Rep
Giner-Pérez L, Jarquín-Díaz VH, Leone P, Giménez-Garzó C, Mincheva G, Mira Á, Forslund-Startceva SK, Rubio T, Felipo V, Pérez-Martínez G, Llansola M.   +10 more
europepmc   +1 more source

Association of pharmacotherapy with all-cause mortality among patients with irritable bowel syndrome. [PDF]

Commun Med (Lond)
Mehravar S, Yeo YH, Pimentel M, Naji P, Ng WH, Burger N, Takakura W, Rezaie A.   +7 more
europepmc   +1 more source

Lactulose, Rifaximin, and Survival in Hepatic Encephalopathy: A Cohort Study of 120 Patients. [PDF]

J Clin Med
Alexandrescu L, Tofolean IT, Aftenie C, Alexandrescu DM, Tofolean DE, Nicoara AD, Stanigut AM, Nelson Twakor A, Rusu E, Dumitru E, Dumitru A, Tocia C, Herlo A, Mihu MA, Popescu I, Dina E, Cimpineanu B.   +16 more
europepmc   +1 more source

Pockets of Trouble: Diffuse Jejunal Diverticulosis Causing Refractory Intestinal Microbial Overgrowth. [PDF]

ACG Case Rep J
Cruz E, Sukov R, Lim J.
europepmc   +1 more source

Unraveling the Complexities of Small Intestinal Bacterial Overgrowth. [PDF]

Medicina (Kaunas)
Capuano E, Del Gaudio A, Nista EC, De Lucia SS, Pellegrino A, Cuccia G, Saviano A, Petruzziello C, Ojetti V.   +8 more
europepmc   +1 more source